Jefferies Financial Group Begins Coverage on Solventum (NYSE:SOLV)

Key Points

• Jefferies Financial Group initiated coverage on Solventum (NYSE:SOLV) with a "hold" rating and a price target of $80.00, indicating a potential upside of 12.29% from its previous close.
• In recent assessments, various analysts have shown mixed ratings for Solventum, with a consensus of "Hold" and an average price target of $85.11 based on reports from multiple institutions.
• Solventum's recent earnings report showed earnings per share (EPS) of $1.69, surpassing estimates, with a year-over-year revenue increase of 3.8%, reinforcing the company's positive outlook for FY 2025 earnings guidance.

Analysts at Jefferies Financial Group assumed coverage on shares of Solventum (NYSE:SOLV - Get Free Report) in a report issued on Thursday,Benzinga reports. The firm set a "hold" rating and a $80.00 price target on the stock. Jefferies Financial Group's target price points to a potential upside of 12.29% from the stock's previous close.

SOLV has been the topic of several other research reports. Piper Sandler reiterated an "overweight" rating and issued a $94.00 price objective (up previously from $87.00) on shares of Solventum in a research note on Friday, August 8th. Morgan Stanley upgraded Solventum from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $80.00 to $103.00 in a research report on Tuesday, July 15th. Argus upgraded Solventum from a "hold" rating to a "buy" rating and set a $90.00 price target for the company in a research report on Tuesday, July 1st. KeyCorp assumed coverage on Solventum in a research report on Friday, June 6th. They issued a "sector weight" rating for the company. Finally, Wall Street Zen cut Solventum from a "strong-buy" rating to a "buy" rating in a research report on Tuesday. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Solventum presently has a consensus rating of "Hold" and an average price target of $85.11.

Solventum Trading Down 2.3%

Solventum stock opened at $71.25 on Thursday. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.14. The business's fifty day simple moving average is $73.27 and its two-hundred day simple moving average is $72.75. Solventum has a 12 month low of $60.70 and a 12 month high of $85.92. The company has a market capitalization of $12.35 billion, a price-to-earnings ratio of 32.98, a price-to-earnings-growth ratio of 2.98 and a beta of 0.53.

Solventum (NYSE:SOLV - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.24. The firm had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a return on equity of 29.93% and a net margin of 4.52%.The company's quarterly revenue was up 3.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.56 earnings per share. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, equities analysts predict that Solventum will post 6.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Solventum

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SOLV. Rossby Financial LCC bought a new position in Solventum during the first quarter valued at approximately $25,000. Strengthening Families & Communities LLC boosted its holdings in shares of Solventum by 376.8% in the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock worth $25,000 after purchasing an additional 260 shares during the period. CYBER HORNET ETFs LLC purchased a new position in shares of Solventum in the 2nd quarter worth approximately $28,000. Raiffeisen Bank International AG purchased a new position in shares of Solventum in the 4th quarter worth approximately $29,000. Finally, Barrett & Company Inc. boosted its holdings in shares of Solventum by 206.2% in the 2nd quarter. Barrett & Company Inc. now owns 398 shares of the company's stock worth $30,000 after purchasing an additional 268 shares during the period.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.